the design ,synthesis and biological evaluation of heterocyclic compounds as potential targeted anticancer agents

  • Summary

    the objective of this study is to identify noval dual EGFR/ HER2 inhibitors that can be further optimized to attain optimal activity 

  • Achievements


  • List of Publications from the Project


  • Partners

  • Project Members

  • Project Leaders

  • Project PI

    Sandra Nabil Morad

  • Faculty

    Faculty of Pharmacy

  • Research Group

  • Funding Agency

    STDF / STIFA

  • Funding Program

    Demand-Driven Projects (STDF-DDP)

  • Start Date

    2017-05-07

  • End Date

    2018-05-07

  • Sustainable Development Goals (SDGs)

  • Project website